NS Pharma, Inc.
Jennifer Tamberino is an accomplished sales leader with extensive experience in the pharmaceutical and healthcare industries. Currently serving as Senior Director and Head of Sales at NS Pharma, Inc. since August 2020, Jennifer has a strong background in managing sales teams and launching innovative products in various therapeutic areas, including rare diseases and neurology. Previous roles include Regional Business Director at BrightStar Care, Regional Account Manager at Alexion Pharmaceuticals, and multiple leadership positions at Biogen, where significant achievements included the successful launch of Natalizumab for Multiple Sclerosis. Jennifer holds a Bachelor's degree in Psychology from Washington College and has obtained a Six Sigma Black Belt certification, underscoring expertise in management and strategic development.
This person is not in any offices
NS Pharma, Inc.
2 followers
NS Pharma, Inc. (NSP) located in Paramus New Jersey is a subsidiary of Nippon Shinyaku Co., Ltd. Founded in 1999 in the United States, NSP is engaged in clinical studies and partnering with global pharmaceutical companies, venture companies and research institutes. NSP serves as a contact point for connecting Japan/Asia and the world, developing drug candidates invented in Japan and out-license them to the world. From the world to Japan/Asia, NSP in-license promising drug candidates to the Japanese/Asian Markets. In coordination with parent company, Nippon Shinyaku, Co., Ltd., NSP will first and foremost develop and supply safe and highly effective pharmaceuticals through clinical studies. NSP aims to be an indispensable entity in the healthcare industry in line with the guidelines for action “Challenge”, “Speed”, and “Investigation”.